Skip to main content
Top
Published in: Journal of Cancer Survivorship 4/2013

01-12-2013

Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment

Authors: Jennifer S. Ford, Joanne F. Chou, Charles A. Sklar

Published in: Journal of Cancer Survivorship | Issue 4/2013

Login to get access

Abstract

Purpose

Due to their heightened risk of developing late-occurring adverse outcomes, pediatric cancer survivors are advised to receive follow-up care in specialized Survivor Clinics. However, little is known about the impact of attending such clinics on psychosocial adjustment, knowledge, and morbidity. This study assesses the differences between those who attended a Survivorship Clinic and those who did not on knowledge, perception of risk, and psychosocial adjustment.

Methods

We assessed 102 survivors who attended our Long-Term Follow-Up (LTFU) Clinic and 71 survivors never seen in a specialized clinic (non-LTFU). Participants were diagnosed at least 5 years prior to the assessment, were at least 20 years old, and had no evidence of active disease. Groups were matched on gender, age at cancer diagnosis, diagnosis, and race.

Results

On average, participants were currently 30 years of age and had been diagnosed with cancer around age 12. Most common reasons that non-LTFU survivors did not attend the clinic were “not aware” (71 %) or “not interested” (16 %). Survivors in each group were able to accurately report their cancer diagnosis, but few knew specific treatment information. There were no significant differences regarding survivors’ perceptions of risk of future health problems with both groups similarly underestimating their risks. A significant minority in each group reported psychological or emotional problems (16–18 %), post-traumatic stress disorder (4.2–6.9 %), and/or psychological distress (7.8–19.7 %).

Conclusions

Survivors are in need of continued education about their specific cancer treatments, recommended follow-up practices, the importance of survivorship care, and their specific risks for late effects.

Implications for Cancer Survivors

Among those childhood cancer survivors who do attend a Survivor clinic, a majority are in need of continued education about their specific cancer treatments, recommended follow-up practices, and risk of late effects. As many survivors of pediatric cancer appear to be unaware of the existence of Survivor clinics, improved methods of transitioning survivors after completion of treatment are needed.
Literature
3.
4.
go back to reference Sklar CA. Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediatr Suppl. 1999;88(433):1–4.PubMedCrossRef Sklar CA. Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediatr Suppl. 1999;88(433):1–4.PubMedCrossRef
5.
go back to reference Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit Jr ME, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol: Off J Am Soc Clin Oncol. 2001;19(13):3163–72. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit Jr ME, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol: Off J Am Soc Clin Oncol. 2001;19(13):3163–72.
6.
go back to reference Zeltzer LK, Recklitis C, Buchbinder D, Zebrack B, Casillas J, Tsao JC, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol: Off J Am Soc Clin Oncol. 2009;27(14):2396–404. doi:10.1200/JCO.2008.21.1433.CrossRef Zeltzer LK, Recklitis C, Buchbinder D, Zebrack B, Casillas J, Tsao JC, et al. Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Clin Oncol: Off J Am Soc Clin Oncol. 2009;27(14):2396–404. doi:10.​1200/​JCO.​2008.​21.​1433.CrossRef
7.
go back to reference Hobbie WL, Stuber M, Meeske K, Wissler K, Rourke MT, Ruccione K, et al. Symptoms of posttraumatic stress in young adult survivors of childhood cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2000;18(24):4060–6. Hobbie WL, Stuber M, Meeske K, Wissler K, Rourke MT, Ruccione K, et al. Symptoms of posttraumatic stress in young adult survivors of childhood cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2000;18(24):4060–6.
8.
go back to reference Joubert D, Sadeghi MR, Elliott M, Devins GM, Laperriere N, Rodin G. Physical sequelae and self-perceived attachment in adult survivors of childhood cancer. Psychooncology. 2001;10(4):284–92.PubMedCrossRef Joubert D, Sadeghi MR, Elliott M, Devins GM, Laperriere N, Rodin G. Physical sequelae and self-perceived attachment in adult survivors of childhood cancer. Psychooncology. 2001;10(4):284–92.PubMedCrossRef
9.
go back to reference Lansky SB, List MA, Ritter-Sterr C. Psychosocial consequences of cure. Cancer. 1986;58(2):529–33.PubMedCrossRef Lansky SB, List MA, Ritter-Sterr C. Psychosocial consequences of cure. Cancer. 1986;58(2):529–33.PubMedCrossRef
10.
go back to reference Mulhern RK, Wasserman AL, Friedman AG, Fairclough D. Social competence and behavioral adjustment of children who are long-term survivors of cancer. Pediatrics. 1989;83(1):18–25.PubMed Mulhern RK, Wasserman AL, Friedman AG, Fairclough D. Social competence and behavioral adjustment of children who are long-term survivors of cancer. Pediatrics. 1989;83(1):18–25.PubMed
11.
go back to reference Zeltzer LK, Chen E, Weiss R, Guo MD, Robison LL, Meadows AT, et al. Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a cooperative Children’s Cancer Group and National Institutes of Health study. J Clin Oncol: Off J Am Soc Clin Oncol. 1997;15(2):547–56. Zeltzer LK, Chen E, Weiss R, Guo MD, Robison LL, Meadows AT, et al. Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a cooperative Children’s Cancer Group and National Institutes of Health study. J Clin Oncol: Off J Am Soc Clin Oncol. 1997;15(2):547–56.
12.
go back to reference National Cancer Policy Board (U.S.), Weiner SL, Simone JV. Childhood cancer survivorship: improving care and quality of life. Washington, DC: National Academies Press; 2003. National Cancer Policy Board (U.S.), Weiner SL, Simone JV. Childhood cancer survivorship: improving care and quality of life. Washington, DC: National Academies Press; 2003.
15.
go back to reference Hollen PJ, Hobbie WL. Establishing comprehensive specialty follow-up clinics for long-term survivors of cancer. Providing systematic physiological and psychosocial support. Support Care Cancer. 1995;3(1):40–4.PubMedCrossRef Hollen PJ, Hobbie WL. Establishing comprehensive specialty follow-up clinics for long-term survivors of cancer. Providing systematic physiological and psychosocial support. Support Care Cancer. 1995;3(1):40–4.PubMedCrossRef
16.
go back to reference Neglia JP, Nesbit Jr ME. Care and treatment of long-term survivors of childhood cancer. Cancer. 1993;71(10):3386–91.PubMedCrossRef Neglia JP, Nesbit Jr ME. Care and treatment of long-term survivors of childhood cancer. Cancer. 1993;71(10):3386–91.PubMedCrossRef
17.
go back to reference Hewitt ME, Greenfield S, Stovall E. National Cancer Policy Board (U.S.). Committee on Cancer Survivorship: Improving Care and Quality of Life. From cancer patient to cancer survivor: lost in transition. Washington, D.C.: National Academies Press; 2006. Hewitt ME, Greenfield S, Stovall E. National Cancer Policy Board (U.S.). Committee on Cancer Survivorship: Improving Care and Quality of Life. From cancer patient to cancer survivor: lost in transition. Washington, D.C.: National Academies Press; 2006.
20.
go back to reference Blacklay A, Eiser C, Ellis A. Development and evaluation of an information booklet for adult survivors of cancer in childhood. The United Kingdom Children’s Cancer Study Group Late Effects Group. Arch Dis Child. 1998;78(4):340–4.PubMedCrossRef Blacklay A, Eiser C, Ellis A. Development and evaluation of an information booklet for adult survivors of cancer in childhood. The United Kingdom Children’s Cancer Study Group Late Effects Group. Arch Dis Child. 1998;78(4):340–4.PubMedCrossRef
21.
go back to reference Eiser C, Hill JJ, Blacklay A. Surviving cancer; what does it mean for you? An evaluation of a clinic based intervention for survivors of childhood cancer. Psychooncology. 2000;9(3):214–20.PubMedCrossRef Eiser C, Hill JJ, Blacklay A. Surviving cancer; what does it mean for you? An evaluation of a clinic based intervention for survivors of childhood cancer. Psychooncology. 2000;9(3):214–20.PubMedCrossRef
22.
go back to reference Hudson MM, Tyc VL, Jayawardene DA, Gattuso J, Quargnenti A, Greenwald C, et al. Feasibility of implementing health promotion interventions to improve health-related quality of life. Int J Cancer Suppl. 1999;12:138–42.PubMedCrossRef Hudson MM, Tyc VL, Jayawardene DA, Gattuso J, Quargnenti A, Greenwald C, et al. Feasibility of implementing health promotion interventions to improve health-related quality of life. Int J Cancer Suppl. 1999;12:138–42.PubMedCrossRef
23.
go back to reference Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, et al. Childhood cancer survivors’ knowledge about their past diagnosis and treatment—Childhood Cancer Survivor Study. JAMA. 2002;287(14):1832–9.PubMedCrossRef Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, et al. Childhood cancer survivors’ knowledge about their past diagnosis and treatment—Childhood Cancer Survivor Study. JAMA. 2002;287(14):1832–9.PubMedCrossRef
26.
go back to reference Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.PubMedCrossRef Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.PubMedCrossRef
27.
go back to reference Derogatis LR. Brief Symptom Inventory (BSI) administration, scoring & procedures manual. Minneapolis: National Computer Systems, Persons; 1993. Derogatis LR. Brief Symptom Inventory (BSI) administration, scoring & procedures manual. Minneapolis: National Computer Systems, Persons; 1993.
29.
go back to reference Weathers FW, Ford J. Psychometric properties of the PTSD checklist (PCL-C, PCL-S, PCL-M, PCL-PR). In: Stamm BH, editor. Measurement of stress, trauma, and adaptation. Lutherville: Sidran; 1996. p. ix. 445 p. Weathers FW, Ford J. Psychometric properties of the PTSD checklist (PCL-C, PCL-S, PCL-M, PCL-PR). In: Stamm BH, editor. Measurement of stress, trauma, and adaptation. Lutherville: Sidran; 1996. p. ix. 445 p.
30.
go back to reference Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Annual Meeting of the International Society for Traumatic Stress Studies; San Antonio, Texas 1993. Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Annual Meeting of the International Society for Traumatic Stress Studies; San Antonio, Texas 1993.
31.
go back to reference Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–71.PubMedCrossRef Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9(3):455–71.PubMedCrossRef
32.
go back to reference Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981;4(3):213–20.PubMedCrossRef Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981;4(3):213–20.PubMedCrossRef
33.
go back to reference Weiss DS. The Impact of Event Scale—Revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. 2nd ed. New York: Guilford; 2004. p. xvii. 668 p. Weiss DS. The Impact of Event Scale—Revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. 2nd ed. New York: Guilford; 2004. p. xvii. 668 p.
34.
go back to reference Werba BE, Hobbie W, Kazak AE, Ittenbach RF, Reilly AF, Meadows AT. Classifying the intensity of pediatric cancer treatment protocols: The Intensity of Treatment Rating Scale 2.0 (ITR-2). Pediatr Blood Cancer. 2007;48(7):673–7. doi:10.1002/Pbc.21184.PubMedCrossRef Werba BE, Hobbie W, Kazak AE, Ittenbach RF, Reilly AF, Meadows AT. Classifying the intensity of pediatric cancer treatment protocols: The Intensity of Treatment Rating Scale 2.0 (ITR-2). Pediatr Blood Cancer. 2007;48(7):673–7. doi:10.​1002/​Pbc.​21184.PubMedCrossRef
35.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodol. 1995;57(1):289–300. Benjamini Y, Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodol. 1995;57(1):289–300.
36.
go back to reference Brabant G, Toogood AA, Shalet SM, Frobisher C, Lancashire ER, Reulen RC, et al. Hypothyroidism following childhood cancer therapy—an under diagnosed complication. Int J Cancer. 2012;130(5):1145–50. doi:10.1002/ijc.26086.PubMedCrossRef Brabant G, Toogood AA, Shalet SM, Frobisher C, Lancashire ER, Reulen RC, et al. Hypothyroidism following childhood cancer therapy—an under diagnosed complication. Int J Cancer. 2012;130(5):1145–50. doi:10.​1002/​ijc.​26086.PubMedCrossRef
Metadata
Title
Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment
Authors
Jennifer S. Ford
Joanne F. Chou
Charles A. Sklar
Publication date
01-12-2013
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-013-0291-9

Other articles of this Issue 4/2013

Journal of Cancer Survivorship 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine